10.1002/ejoc.201801123
European Journal of Organic Chemistry
FULL PAPER
determined by HPLC analysis using Daicel Chiralcel OJ-H column (25
cm × 0.46 cm ID), conditions: n-Heptane/i-PrOH = 80/20, 0.5 mL/min,
240 nm; tmajor = 14.9 min, tminor = 17.5 min.
(R)-4-chloro-N-(1-phenylethyl)benzenesulfonamide (2o)
White solid, 87% yield, 97% ee. Mp 104-105 oC. [α]D20 = +57.4 (c = 0.92,
CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 7.65–7.56 (m, 2H), 7.33–7.26 (m,
2H), 7.21–7.13 (m, 3H), 7.10–7.03 (m, 2H), 5.48 (d, J = 7.2 Hz, 1H),
4.58–4.42 (m, 1H), 1.43 (d, J = 6.9 Hz, 3H). The ee of 2o was
determined by HPLC analysis using Daicel Chiralcel OJ-H column (25
cm × 0.46 cm ID), conditions: n-Heptane/i-PrOH = 70/30, 1.0 mL/min,
240 nm; tminor = 8.8 min, tmajor = 14.6 min.
(R)-N-(1-(4-bromophenyl)ethyl)benzenesulfonamide (2h)
White solid, 68% yield, 97% ee. Mp 151-154 oC. [α]D20 = +43.5 (c = 0.2,
CH2Cl2).1H NMR (400 MHz, CDCl3) δ 7.68–7.58 (m, 2H), 7.44 (t, J = 7.5
Hz, 1H), 7.31 (s, 2H), 7.20 (d, J = 8.3 Hz, 2H), 6.89 (d, J = 8.4 Hz, 2H),
5.22 (d, J = 7.0 Hz, 1H), 4.43–4.33 (m, 1H), 1.31 (d, J = 6.9 Hz, 3H). The
ee of 2h was determined by HPLC analysis using Daicel Chiralcel AS-H
column (25 cm × 0.46 cm ID), conditions: n-Heptane/i-PrOH = 70/30, 1.0
mL/min, 240 nm; tmajor = 13.8 min, tminor = 20.1 min.
(R)-N-(1-phenylethyl)methanesulfonamide (2p)
Colorless oil, 82% yield, 97% ee. [α]D20 = +56.2 (c = 0.24, CH2Cl2). 1H
NMR (400 MHz, CDCl3) δ 7.33–7.30 (m, 1H), 7.29 (t, J = 2.7 Hz, 2H),
7.27–7.18 (m, 2H), 4.97 (d, J = 6.4 Hz, 1H), 4.58 (s, 1H), 2.53 (s, 3H),
1.47 (s, 3H).The ee of 2p was determined by HPLC analysis using Daicel
Chiralcel AS-H column (25 cm × 0.46 cm ID), conditions: n-Heptane/i-
PrOH = 80/20, 1.0 mL/min, 220 nm; tmajor = 12.7 min, tminor = 18.1 min.
(R)-N-(1-(naphthalen-1-yl)ethyl)benzenesulfonamide (2i)
White solid, 70% yield, 99% ee. Mp 161-163 oC. [α]D20 = -2.5 (c = 0.58,
CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 7.91 (dd, J = 5.4, 4.3 Hz, 1H), 7.78
(dd, J = 6.8, 2.7 Hz, 1H), 7.71–7.60 (m, 3H), 7.49–7.40 (m, 2H), 7.36 (dd,
J = 14.9, 7.4 Hz, 2H), 7.24 (dt, J = 12.9, 6.5 Hz, 3H), 5.56 (d, J = 6.9 Hz,
1H), 5.38–5.27 (m, 1H), 1.57 (d, J = 6.8 Hz, 3H). The ee of 2i was
determined by HPLC analysis using Daicel Chiralcel OD-H column (25
cm × 0.46 cm ID), conditions: n-Heptane/i-PrOH = 80/20, 0.5 mL/min,
240 nm; tmajor = 17.7 min, tminor = 23.8 min.
(S)-3-phenyl-2,3-dihydrobenzo[d]isothiazole-1,1-dioxide (4a)
White solid, 91% yield, 88% ee. Mp 128-131 oC. [α]D20 = +85.2 (c = 0.46,
CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 7.87–7.81 (m, 1H), 7.57 (dd, J =
6.4, 2.8 Hz, 2H), 7.40 (d, J = 4.2 Hz, 5H), 7.18–7.12 (m, 1H), 5.74 (d, J =
4.1 Hz, 1H), 5.14 (d, J = 3.2 Hz, 1H). The ee of 4a was determined by
HPLC analysis using Daicel Chiralcel OD-H column (25 cm × 0.46 cm ID),
conditions: n-Heptane/i-PrOH = 70/30, 0.8 mL/min, 230 nm; tmajor = 18.5
min, tminor = 21.0 min.
(R)-N-(1-(thiophen-2-yl)ethyl)benzenesulfonamide (2j)
White solid, 90% yield, 95% ee. Mp 92-95 oC. [α]D20 = +49.0 (c = 0.2,
CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 7.84 (d, J = 7.4 Hz, 2H), 7.55 (s,
1H), 7.47 (d, J = 7.8 Hz, 2H), 7.11 (d, J = 5.1 Hz, 1H), 6.88–6.72 (m, 2H),
5.35 (d, J = 7.1 Hz, 1H), 4.79 (s, 1H), 1.55 (d, J = 6.8 Hz, 3H). The ee of
2j was determined by HPLC analysis using Daicel Chiralcel OD-H
column (25 cm × 0.46 cm ID), conditions: n-Heptane/i-PrOH = 90/10, 1.0
mL/min, 240 nm; tmajor = 12.7 min, tminor = 14.6 min.
(S)-3-(p-tolyl)-2,3-dihydrobenzo[d]isothiazole-1,1-dioxide (4b)
White solid, 89% yield, 90% ee. Mp 169-171 oC. [α]D20 = +66.5 (c = 0.52,
CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 7.83 (dd, J = 5.9, 2.8 Hz, 1H),
7.61–7.51 (m, 2H), 7.30–7.24 (m, 2H), 7.21 (d, J = 8.0 Hz, 2H), 7.15 (dd,
J = 5.4, 2.9 Hz, 1H), 5.70 (d, J = 3.9 Hz, 1H), 5.06 (d, J = 3.3 Hz, 1H),
2.37 (s, 3H). The ee of 4b was determined by HPLC analysis using
Daicel Chiralcel AS-H column (25 cm × 0.46 cm ID), conditions: n-
(R)-N-(1-phenylpropyl)benzenesulfonamide (2k)
White solid, 85% yield, 96% ee. Mp 117-120 oC. [α]D20 = +62.9 (c = 0.88,
CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 7.63–7.55 (m, 2H), 7.33 (d, J = 7.5
Hz, 1H), 7.21 (dd, J = 15.0, 7.5 Hz, 2H), 7.04 (dd, J = 4.2, 2.3 Hz, 3H),
6.92 (dd, J = 6.6, 2.9 Hz, 2H), 5.32 (d, J = 7.6 Hz, 1H), 4.14 (q, J = 7.4
Hz, 1H), 1.74 (dd, J = 14.1, 7.0 Hz, 1H), 1.68–1.60 (m, 1H), 0.72 (t, J =
7.4 Hz, 3H). The ee of 2k was determined by HPLC analysis using Daicel
Chiralcel AD-H column (25 cm × 0.46 cm ID), conditions: n-Heptane/i-
PrOH 95/5, 0.5 mL/min, 240 nm; tminor = 51.6 min, tmajor = 54.8 min.
Heptane/i-PrOH = 70/30, 0.5 mL/min, 230 nm; tmajor = 17.4 min, tminor
23.0 min.
=
(S)-3-(4-fluorophenyl)-2,3-dihydrobenzo[d]isothiazole-1,1-dioxide
(4c)
White solid, 92% yield, 85% ee. Mp 163-67 oC. [α]D20 = +66.9 (c = 0.76,
CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 7.89–7.81 (m, 1H), 7.58 (d, J = 2.8
Hz, 2H), 7.37 (dd, J = 8.6, 5.2 Hz, 2H), 7.15 (dd, J = 7.6, 5.8 Hz, 1H),
7.10 (d, J = 8.6 Hz, 2H), 5.75 (d, J = 4.1 Hz, 1H), 5.23 (d, J = 3.3 Hz,
1H).The ee of 4c was determined by HPLC analysis using Daicel
Chiralcel OD-H column (25 cm × 0.46 cm ID), conditions: n-Heptane/i-
PrOH = 70/30, 1.0 mL/min, 230 nm; tmajor = 9.8 min, tminor = 15.6 min.
(R)-2-methyl-N-(1-phenylethyl)benzenesulfonamide (2l)
White solid, 72% yield, 95% ee. Mp 87-90 oC. [α]D20 = +61.2 (c = 0.76,
CH2Cl2.1H NMR (400 MHz, CDCl3) δ 7.86 (d, J = 7.8 Hz, 1H), 7.37 (s, 1H),
7.17 (dd, J = 14.1, 4.9 Hz, 5H), 7.09–6.99 (m, 2H), 5.13 (s, 1H), 4.43 (s,
1H), 2.52 (s, 3H), 1.45 (d, J = 6.8 Hz, 3H). The ee of 2l was determined
by HPLC analysis using Daicel Chiralcel OJ-H column (25 cm × 0.46 cm
(S)-3-methyl-2,3-dihydrobenzo[d]isothiazole-1,1-dioxide (4d)
ID), conditions: n-Heptane/i-PrOH = 80/20, 0.5 mL/min, 240 nm; tminor
15.2 min, tmajor = 26.6 min.
=
White solid, 84% yield, 81% ee. Mp 92-95 oC. [α]D20 = -20 (c = 0.38,
CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 7.4 Hz, 1H), 7.64 (t, J
= 7.5 Hz, 1H), 7.53 (t, J = 7.4 Hz, 1H), 7.40 (d, J = 7.7 Hz, 1H), 5.12 (d, J
= 27.5 Hz, 1H), 4.87–4.75 (m, 1H), 1.61 (dd, J = 6.6, 2.6 Hz, 3H). The ee
of 4d was determined by HPLC analysis using Daicel Chiralcel OD-H
column (25 cm × 0.46 cm ID), conditions: n-Heptane/i-PrOH = 80/20, 0.5
mL/min, 230 nm; tmajor = 23.0 min, tminor = 29.5 min.
(R)-3-methyl-N-(1-phenylethyl)benzenesulfonamide (2m)
White solid, 82% yield, 98% ee. Mp 145-147 oC. [α]D20 = +75.0 (c = 0.58,
CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 7.61–7.54 (m, 1H), 7.50 (s, 1H),
7.28 (dd, J = 3.9, 1.6 Hz, 2H), 7.24–7.15 (m, 3H), 7.14–7.07 (m, 2H),
5.25 (d, J = 7.1 Hz, 1H), 4.51 (s, 1H), 2.32 (s, 3H), 1.46 (d, J = 6.9 Hz,
3H). The ee of 2n was determined by HPLC analysis using Daicel
Chiralcel OD-H column (25 cm × 0.46 cm ID), conditions: n-Heptane/i-
PrOH = 90/10, 1.0 mL/min, 240 nm; tmajor = 10.9 min, tminor = 12.3 min.
(S)-3-phenethyl-2,3-dihydrobenzo[d]isothiazole-1,1-dioxide (4e)
White solid, 93% yield, 71% ee. Mp 111-114 oC. [α]D20 = -32.8 (c = 0.6,
CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 7.78 (d, J = 7.7 Hz, 1H), 7.62 (s,
1H), 7.53 (s, 1H), 7.34 (dd, J = 21.6, 7.5 Hz, 3H), 7.24 (dd, J = 7.0, 4.8
Hz, 3H), 5.19 (d, J = 5.2 Hz, 1H), 4.79–4.64 (m, 1H), 2.84 (t, J = 7.7 Hz,
2H), 2.28 (d, J = 3.5 Hz, 1H), 2.18–2.05 (m, 1H). The ee of 4e was
determined by HPLC analysis using Daicel Chiralcel AS-H column (25
cm × 0.46 cm ID), conditions: n-Heptane/i-PrOH = 70/30, 0.5 mL/min,
230 nm; tmajor = 43.0 min, tminor = 52.2 min.
(R)-4-methyl-N-(1-phenylethyl)benzenesulfonamide (2n)
White solid, 94% yield, 97% ee. Mp 99-102 oC. [α]D20 = +68.5 (c = 0.26,
CH2Cl2). 1H NMR (400 MHz, CDCl3) δ 7.62 (d, J = 8.3 Hz, 2H), 7.16 (dd,
J = 4.8, 3.1 Hz, 5H), 7.10 (dt, J = 5.1, 3.9 Hz, 2H), 5.23 (d, J = 7.1 Hz,
1H), 4.53–4.38 (m, 1H), 2.37 (s, 3H), 1.41 (d, J = 6.9 Hz, 3H). The ee of
2m was determined by HPLC analysis using Daicel Chiralcel OJ-H
column (25 cm × 0.46 cm ID), conditions: n-Heptane/i-PrOH = 70/30, 1.0
mL/min, 240 nm; tminor = 12.6 min, tmajor = 18.9 min.
This article is protected by copyright. All rights reserved.